-
AbbVie Inc. (ABBV $191.52)
-
Abbott Laboratories (ABT $132.03)
-
Eli Lilly and Company (LLY $799.34)
-
Novo Nordisk A/S (NVO $68.94)
-
iShares U.S. Medical Devices ETF (IHI $61.20)
Q: I am underwhelmed with my health sector holdings - ABBV and IHI - both of which have been recently underperforming the market. I have held each for several years in a cash account and they are up 20% and 50%, respectively. I would appreciate your go forward recommendation on both, balancing future prospects, tax consequences and alternative (i.e. faster growing) investments in this sector. Hold or sell? And if sell, replace with what? Thank you.